Developer docs
API playgroundTry for free, no card

Search company profiles

EquiFlow

Full company profile

uuid002wgvf

Namestring
EquiFlow
Legal namestring
Zooomy MegaHA Supplements
Websiteurl
flow-vet.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

EquiFlow, trading commercially as Zooomy MegaHA Supplements, is a privately-held UK veterinary products company that develops and sells oral liquid hyaluronic acid joint supplements for companion animals (dogs and cats). The company was founded by Joanna and Humphrey Grimmett, a husband-and-wife veterinary team, and is headquartered in London. Its core offering is a focused two-SKU line built around a single proprietary formulation: long-chain hyaluronic acid (700,000–1,000,000 molecular weight) produced via microbial fermentation, combined with vitamin C to support cartilage synthesis. The company positions its long-chain HA as functionally distinct from competitor short-chain HA on the basis of claimed oral absorption and joint concentration within one hour.

The business operates a direct-to-consumer model with no disclosed retail or distribution partnerships. Products are sold through the company's own Shopify-powered e-commerce storefront (zooomy.com) at $24 (dog) and $19 (cat) per bottle, with an Appstle-powered subscription tier offering a 20% discount and full pause/cancel flexibility. The storefront supports multi-currency checkout and global shipping, with explicit operating geographies including the UK and US. Marketing is digital-first and concentrated on organic social (Facebook, Instagram, TikTok), content/educational assets, customer reviews, and an emerging affiliate program.

Scale indicators are modest: 1–10 employees, no institutional funding or acquisitions disclosed, and cumulative sales of 35,000+ bottles since launch against 1,000+ verified reviews (4.8★). Revenue is generated almost entirely from a single product technology deployed across two SKUs and a single end-customer segment (individual pet owners), making the business a category specialist rather than a diversified platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pet joint supplements, hyaluronic acid supplements, veterinary pet care, canine joint support, feline joint health
Industry2 codes
PRIMARYHLAMALAO
Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine)
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
NAICS code1 code
  • Pet and Pet Supplies Retailers45991
Product category
Pet Health Supplements
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Product Sales - One-time Purchase
TypeOne Time License
Description

Direct consumer purchases of hyaluronic acid joint supplements for dogs and cats at fixed unit prices ($24 dog, $19 cat).

zooomy.com
2Subscription/Recurring Revenue
TypeSubscription Recurring
Description

Subscription model offering 20% discount with pause/cancel anytime flexibility. Provides predictable recurring revenue and customer lifetime value.

zooomy.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details4 tiers
1Dog Supplement - One-time Purchase
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$24.00 USD per bottle for dogs. Starter bundle available with 90+ day trial.

zooomy.com
2Dog Supplement - Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

$24.00 USD with 20% subscription discount. Flexible subscription with pause, skip, reschedule, or cancel anytime.

zooomy.com
3Cat Supplement - Single Purchase
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$19.00 USD per 60ml bottle for cats.

zooomy.com
4Cat Supplement - Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Subscription options for small cats (<5kg) and large cats (>5kg) with 20% savings.

zooomy.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Zooomy Companion App
Description

Mobile application for managing pet supplement subscriptions and tracking.

zooomy.com
Core offering1 text field

EquiFlow develops and sells oral liquid hyaluronic acid joint supplements for dogs and cats under the Zooomy brand, manufactured as a proprietary veterinary-formulated product line. The company markets these supplements direct-to-consumer through its own e-commerce storefront, offering both one-time purchases and recurring subscription plans, with the dog SKU priced at $24 per bottle and the cat SKU at $19 per bottle.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Dogs with joint problems can have 90% less hyaluronic acid in their joints
+1 more record
Product overview1 text field

Zooomy offers a focused product line of veterinary-developed oral liquid joint supplements for companion animals. The portfolio consists of two core products: Zooomy Hyaluronic Acid Joint Support for Dogs and Zooomy Hyaluronic Acid Joint Support for Cats. Both products contain identical formulations of long-chain hyaluronic acid (molecular weight 700,000 - 1 million units) and Vitamin C, delivered as tasteless, odorless liquids for easy administration. The company also provides a companion mobile app and subscription management through Appstle.

Product and service1 record
1Zooomy Hyaluronic Acid Joint Support for Dogs
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Major global animal health company with nutraceutical and pharmaceutical joint care products. Represents a large, well-resourced competitor in the broader veterinary joint health space where Zooomy operates.

TypeDirect peer
Description

DTC pet wellness brand selling joint, skin, and calming supplements online. Comparable target market, similar subscription-based GTM, and overlapping product positioning with Zooomy.

3Zesty Paws
TypeDirect peer
Description

DTC subscription-led pet supplement brand offering joint, skin, and multivitamin chews. Comparable to Zooomy in target customer (pet owners), business model (DTC + subscription), and category breadth, though with a chewable rather than liquid format.

TypeBroad incumbent
Description

Veterinarian-formulated pet wellness brand under the broader Bayer/Elanco pet care portfolio. Comparable target customer and vet-formulated positioning, but with a much broader product range and larger marketing footprint.

TypeBroad incumbent
Description

Long-standing manufacturer of pet supplements including joint, calming, and skin products. Overlaps Zooomy's joint category but distributes via retail and vet channels rather than DTC subscription.

TypeDirect peer
Description

Maker of Cosequin and Dasuquin, the dominant veterinary joint supplement brands for dogs and cats. Directly competes with Zooomy in the same joint-health category with established vet channel distribution and broad retail presence.

TypeDirect peer
Description

Veterinarian-formulated pet supplement maker with a joint support SKU and similar 'recommended by vets' positioning. Comparable formulation philosophy (condition-specific nutraceuticals) and target customer base.

TypeBroad incumbent
Description

Largest pure-play animal health company, offering a broad portfolio of veterinary therapeutics and supplements. Adjacent incumbent shaping the standard of care Zooomy must displace in vet recommendations.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EquiFlow

Pet Health Supplementsflow-vet.com

What EquiFlow does

EquiFlow, trading commercially as Zooomy MegaHA Supplements, is a privately-held UK veterinary products company that develops and sells oral liquid hyaluronic acid joint supplements for companion animals (dogs and cats). The company was founded by Joanna and Humphrey Grimmett, a husband-and-wife veterinary team, and is headquartered in London. Its core offering is a focused two-SKU line built around a single proprietary formulation: long-chain hyaluronic acid (700,000–1,000,000 molecular weight) produced via microbial fermentation, combined with vitamin C to support cartilage synthesis. The company positions its long-chain HA as functionally distinct from competitor short-chain HA on the basis of claimed oral absorption and joint concentration within one hour.

The business operates a direct-to-consumer model with no disclosed retail or distribution partnerships. Products are sold through the company's own Shopify-powered e-commerce storefront (zooomy.com) at $24 (dog) and $19 (cat) per bottle, with an Appstle-powered subscription tier offering a 20% discount and full pause/cancel flexibility. The storefront supports multi-currency checkout and global shipping, with explicit operating geographies including the UK and US. Marketing is digital-first and concentrated on organic social (Facebook, Instagram, TikTok), content/educational assets, customer reviews, and an emerging affiliate program.

Scale indicators are modest: 1–10 employees, no institutional funding or acquisitions disclosed, and cumulative sales of 35,000+ bottles since launch against 1,000+ verified reviews (4.8★). Revenue is generated almost entirely from a single product technology deployed across two SKUs and a single end-customer segment (individual pet owners), making the business a category specialist rather than a diversified platform.

EquiFlow firmographics

Firmographics
Name
EquiFlow
Legal name
Zooomy MegaHA Supplements
Website
https://flow-vet.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

EquiFlow industry classification

Industry
Product category
Pet Health Supplements
NAICS
Pet and Pet Supplies Retailers (45991)
akta.pro industry
PRIMARYHLAMALAO
Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine)
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)

Keywords

  • Pet joint supplements
  • Hyaluronic acid supplements
  • Veterinary pet care
  • Canine joint support
  • Feline joint health

Where EquiFlow is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

EquiFlow business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Product Sales - One-time Purchase: Direct consumer purchases of hyaluronic acid joint supplements for dogs and cats at fixed unit prices ($24 dog, $19 cat).
  2. Subscription/Recurring Revenue: Subscription model offering 20% discount with pause/cancel anytime flexibility. Provides predictable recurring revenue and customer lifetime value.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDog Supplement - One-time Purchase
SubscriptionMonthlyDog Supplement - Subscription
Unit PricingPay-as-you-goCat Supplement - Single Purchase
SubscriptionMonthlyCat Supplement - Subscription

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

EquiFlow product offering

Product offering

Core offering

EquiFlow develops and sells oral liquid hyaluronic acid joint supplements for dogs and cats under the Zooomy brand, manufactured as a proprietary veterinary-formulated product line. The company markets these supplements direct-to-consumer through its own e-commerce storefront, offering both one-time purchases and recurring subscription plans, with the dog SKU priced at $24 per bottle and the cat SKU at $19 per bottle.

Product overview

Zooomy offers a focused product line of veterinary-developed oral liquid joint supplements for companion animals. The portfolio consists of two core products: Zooomy Hyaluronic Acid Joint Support for Dogs and Zooomy Hyaluronic Acid Joint Support for Cats. Both products contain identical formulations of long-chain hyaluronic acid (molecular weight 700,000 - 1 million units) and Vitamin C, delivered as tasteless, odorless liquids for easy administration. The company also provides a companion mobile app and subscription management through Appstle.

Differentiator

Problem solved

Functional benefit

Brands

  • Zooomy Companion App: Mobile application for managing pet supplement subscriptions and tracking.

Products and services

  • Zooomy Hyaluronic Acid Joint Support for Dogs

Quantifiable outcome

  • Dogs with joint problems can have 90% less hyaluronic acid in their joints
  • +1 more outcomes

Companies that use EquiFlow

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

EquiFlow technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

EquiFlow partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

EquiFlow competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Major global animal health company with nutraceutical and pharmaceutical joint care products. Represents a large, well-resourced competitor in the broader veterinary joint health space where Zooomy operates.
  • Vet's Best: Veterinarian-formulated pet wellness brand under the broader Bayer/Elanco pet care portfolio. Comparable target customer and vet-formulated positioning, but with a much broader product range and larger marketing footprint.
  • NaturVet: Long-standing manufacturer of pet supplements including joint, calming, and skin products. Overlaps Zooomy's joint category but distributes via retail and vet channels rather than DTC subscription.
  • Zoetis: Largest pure-play animal health company, offering a broad portfolio of veterinary therapeutics and supplements. Adjacent incumbent shaping the standard of care Zooomy must displace in vet recommendations.

Direct peers

  • Pet Honesty: DTC pet wellness brand selling joint, skin, and calming supplements online. Comparable target market, similar subscription-based GTM, and overlapping product positioning with Zooomy.
  • Zesty Paws: DTC subscription-led pet supplement brand offering joint, skin, and multivitamin chews. Comparable to Zooomy in target customer (pet owners), business model (DTC + subscription), and category breadth, though with a chewable rather than liquid format.
  • Nutramax Laboratories: Maker of Cosequin and Dasuquin, the dominant veterinary joint supplement brands for dogs and cats. Directly competes with Zooomy in the same joint-health category with established vet channel distribution and broad retail presence.
  • Pet Naturals of Vermont: Veterinarian-formulated pet supplement maker with a joint support SKU and similar 'recommended by vets' positioning. Comparable formulation philosophy (condition-specific nutraceuticals) and target customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

EquiFlow social profiles

Digital presence

EquiFlow financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EquiFlow leadership team

Management profile

Number of profiles

Profiles2 records

EquiFlow funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EquiFlow M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EquiFlow

What does EquiFlow do?

EquiFlow develops and sells oral liquid hyaluronic acid joint supplements for dogs and cats under the Zooomy brand, manufactured as a proprietary veterinary-formulated product line. The company markets these supplements direct-to-consumer through its own e-commerce storefront, offering both one-time purchases and recurring subscription plans, with the dog SKU priced at $24 per bottle and the cat SKU at $19 per bottle.

Is EquiFlow a public or private company?

EquiFlow is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was EquiFlow founded?

EquiFlow was founded in -1. It employs 1 to 10 people.

Where is EquiFlow based?

EquiFlow is headquartered in London, United Kingdom, in the Europe region.

How does EquiFlow make money?

Two revenue lines are on record. Product Sales - One-time Purchase is the primary driver. The others are subscription/Recurring Revenue.

Who are EquiFlow's main competitors?

Broad incumbents on record are Elanco Animal Health, Vet's Best, NaturVet and Zoetis. Direct peers are Pet Honesty, Zesty Paws, Nutramax Laboratories and Pet Naturals of Vermont.

Does EquiFlow have an API?

No public API is recorded for EquiFlow.

What industry is EquiFlow in?

EquiFlow's product category is Pet Health Supplements. Its primary akta.pro industry code is HLAMALAO, Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine), with a secondary code of HLAMALAN, Species-Specific Supplements (Dog/Cat/Other Companion Species). Its NAICS code is 45991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales